Abstract
The bradykinin-potentiating factor (BPF) is a component of Bothrops jararaca venom which potentiates in vitro as well as in vivo some pharmacological effects of bradykinin (Ferreira, 1964; 1965). This communication deals with its purification, biochemical characteristics, pharmacological actions,and some considerations of the mechanism of bradykinin potentiation by BPF.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Amorim, D. S., S. H. Ferreira, J. C. Manco, A. Tanaka, A. Sader, and S. S. Cardoso: Potenciacao dos efeitos circulatorios da infusao continua de bradicinina. XXI Congresso Brasileiro de Cardiologia. Arquivos bras. Cardiol, in press (1965).
Corrado, A. P.: Recent investigations of the pharmacology of bradykinin and their physio-pathological implications. Setting. Med. Suppl., 1, 51 (1963).
Erdos, E. G., and E. M. Sloane: An enzyme in human blood plasma that inactivates bradykinin and kallidins. Biochem. Pharmacol. 11, 585 (1962).
Erdos, E. G., and J. R. Wohler: Inhibition in vivo of the enzymatic inactivations of bradykinin and kallidin. Biochem. Pharmacol. 12, 1193 (1963).
Ferreira, S. H.: Potenciacao da bradicinina por fator presente no veneno da bothrops jararaca. Thesis, Fac. Med. Ribeirao Préto (1964).
Ferreira, S. H.: A bradykinin potentiating factor (BPF) present in the venom of Bothrops jararaca. Brit. J. Pharmacol. 24, 163 (1965).
Ferreira, S. H., and M. Rocha e Silva: Potentiation of bradykinin by dimercaptopropanol (BAL) and other inhibitors of its destroying enzyme in plasma. Biochem. Pharmacol. 11, 1123 (1962).
Ferreira, S. H., and M. Rocha e Silva: Potentiation of bradykinin and eledoisin by BPF (bradykinin factor) from Bottrops jararaca venom. Experientia (Basel) 121, 347 (1965).
Ferreira, S. H., A. P. Corrado, and M. Rocha e Silva: Potenciacao do efeito hipotensor da bradicinina por inibicao do enzima bradicininolitico plasmatico. Cigncia e Cultura 14, 238 (1962).
Graeff, F. G., S. H. Ferreira, A. P. Corrado, and M. Rocha e Silva: Potentiation of the cerebral vascular action of bradykinin by the “Bradykinin Potentiating Factor” (BPF) in the dog. Experientia (Basel) 21, 607 (1965).
Olmstedt, F., and I. H. Page: Hemodynamic effects of eledoisin kallidin II and bradykinin in unanesthetized dogs. Amer. J. Physiol. 203, 951 (1962).
Rocha e Silva, M.: The physiological significance of brady-kinin. Ann. N.Y. Acad. Sci. 104, 190 (1963).
Sicuteri, F., P. Fanciullacci, G. Franchi, and S. Michelacci: The endecapetide eledoisin as powerful vasodilating and hypotensive agent in man. Experientia (Basel) 19, 44 (1963).
Stürmer, E., and Berde, A.: A comparative pharmacological study of synthetic eledoisin and synthetic bradykinin. J. Pharmacol, exp. Ther. 140, 349 (1963).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1966 Springer-Verlag New York Inc.
About this paper
Cite this paper
Ferreira, S.H. (1966). Bradykinin-Potentiating Factor. In: Erdös, E.G., Back, N., Sicuteri, F., Wilde, A.F. (eds) Hypotensive Peptides. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-94965-4_35
Download citation
DOI: https://doi.org/10.1007/978-3-642-94965-4_35
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-94967-8
Online ISBN: 978-3-642-94965-4
eBook Packages: Springer Book Archive